Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Penghai Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and chemical intermediates. The company operates significant production facilities that adhere to international quality standards, including GMP certifications, to serve both domestic and global markets. Its product portfolio primarily focuses on small molecule chemistry, covering therapeutic areas such as anti-infectives, cardiovascular health, and gastrointestinal treatments. In addition to its own product line, Penghai Pharmaceutical provides contract manufacturing (CMO) and development services to international pharmaceutical partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Penghai Pharmaceutical.